Xcout Intel
Affinivax, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Affinivax, Inc. among biotechnology companies — ranked by similarity to what Affinivax, Inc. actually does, not by market-cap band.
Subscribe to see Affinivax, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Affinivax, Inc.
Affinivax, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that pioneered a novel class of multiplex vaccine technologies.
Affinivax, Inc. at a glance
Affinivax, Inc. is a biotechnology company headquartered in United States. It has raised at least $353M across the 4 funding rounds on record, 3 of them with a disclosed amount. Its most recent funding round raised $226M in January 2021. Xcout tracks 1 named person at Affinivax, Inc., including Tony Wood (Chief Scientific Officer, GSK).
Affinivax, Inc. leadership
- Tony WoodChief Scientific Officer, GSK
Affinivax, Inc. funding rounds
At least $353M raised across the 4 rounds on record (3 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $226M | — | |
| Series B | $120M | 3 named | |
| SEC Form D filing | $7M | — | |
| Seed and Series A | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Affinivax, Inc. competitors
Ranked by semantic similarity — how close each company is to Affinivax, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Similar biotechnology company
MalarVx, Inc. is a clinical-stage biopharmaceutical vaccine company located in Seattle, Washington, founded to develop innovative vaccines addressing global infectious diseases.
Similar biotechnology company
Icosavax, Inc. is a Seattle, Washington-based clinical-stage biopharmaceutical company specializing in developing novel vaccines utilizing virus-like particle technology.
Similar biotechnology company
Imvax, Inc. is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing personalized, whole-cell immunotherapies for the treatment of various cancers.
Similar biotechnology company
Red Queen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on antiviral therapeutics, with its headquarters located in Cambridge, Massachusetts.
Similar biotechnology company
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Similar biotechnology company
CREATE Medicines is a clinical-stage biotechnology company located in Cambridge, Massachusetts, pioneering in vivo immune programming with RNA.
Similar biotechnology company
Alopexx, Inc. is a U.S. biotechnology company developing broad-spectrum anti-infective vaccines and antibody-based therapies. Its programs target PNAG, a surface polysaccharide found on many bacterial and fungal pathogens, for potential treatment or prevention of serious infections.
Biotech
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Biotech
Repertoire Immune Medicines is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm works to unlock and direct the power of the human immune system to develop novel therapeutics and medicines.
Life Science
Selecta Biosciences, Inc. is a clinical-stage biotechnology company located in Watertown, Massachusetts, focused on unlocking the full potential of biologic therapies. The company engages in advanced biotechnology research and corporate mergers.
Similar biotechnology company
Calder Biosciences Inc. is a nano-scale molecular engineering company founded in 2018 that develops next-generation conformationally-stabilized universal influenza vaccines and other biologics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Affinivax, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Affinivax, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →